Advertisement

IV Saline Solution in Short Supply, Flu May Be to Blame — Physician’s First Watch

Medical News |
January 22, 2014

IV Saline Solution in Short Supply, Flu May Be to Blame

By the Editors

The FDA is reporting a shortage of intravenous solutions, including saline used for volume repletion. The agency says there may be increased demand because of influenza-related hospitalizations. Previously, the agency reported a shortage of the oral suspension of the antiviral oseltamivir (Tamiflu).

In the CDC's most recent flu update, 40 states reported widespread influenza activity, up from 35 the prior week. About 60% of influenza-related hospitalizations were adults under age 65, a pattern consistent with the 2009 H1N1 flu pandemic. This is the first season that the H1N1 strain has been in wide circulation since 2009.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement